Yahoo Finance's Jared Blikre breaks down the stocks Warren Buffett's Berkshire Hathaway is buying and selling.
Pharma giant AbbVie (NYSE: ABBV) has rewarded shareholders in the past decade with market-beating performance. AbbVie's strong showing was primarily a result of its top-selling drug, Humira. If the company manages to replace the medicine, it could deliver many more years of solid performances.
AbbVie (ABBV) receives the option to license worldwide rights for certain IL-2 muteins, including the next-generation inflammatory candidate, CUG252 from Cugene